Literature DB >> 7599817

Bronchoalveolar lavage cellularity in healthy children.

J Riedler1, J Grigg, C Stone, G Tauro, C F Robertson.   

Abstract

The role of bronchoalveolar lavage (BAL) in children remains to be defined, and to date there has been no standardization of acquisition and processing of the BAL fluid. The aim of the present study was to evaluate a standardized protocol for obtaining, processing, and analyzing BAL fluid and to establish reference values for healthy children. Eighteen children 3 mo to 10 yr of age were lavaged with three 1-ml/kg aliquots of normal saline, using a flexible bronchoscope into the right middle lobe. The first aliquot was processed separately; the second and the third were pooled. There was a higher percentage of neutrophils and epithelial cells in the first aliquot. The number of total cells per milliliter (median, Q1 to Q3) in the first aliquot was 60 (45 to 90) x 10(3)/ml; in the pooled sample it was 155 (75 to 257) x 10(3)/ml. Percentages (median, Q1 to Q3) of different cell types in the pooled sample were: macrophages, 91% (84 to 94); lymphocytes, 7.5% (4.7 to 12.8); neutrophils, 1.7% (0.6 to 3.5); eosinophils, 0.15% (0.0 to 0.3). The ratio of helper/cytotoxic T-cells was 0.58 (0.4 to 1). The results of this study demonstrate that BAL, using a standardized protocol adjusting instilled fluid volume by weight, appears to be appropriate in children and that cellular and protein values from healthy children are, apart from differences in lymphocyte subsets, similar to those found in healthy adults.

Entities:  

Mesh:

Year:  1995        PMID: 7599817     DOI: 10.1164/ajrccm.152.1.7599817

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  16 in total

Review 1.  Bronchoalveolar lavage in pediatrics.

Authors:  S Swaminathan; D Vijayasekaran; N Somu
Journal:  Indian J Pediatr       Date:  1996 Mar-Apr       Impact factor: 1.967

Review 2.  The role bronchoscopy in the diagnosis of airway disease in children.

Authors:  Tutku Soyer
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

3.  Bronchoalveolar lavage in children with inflammatory and non inflammatory lung disease.

Authors:  D Gidaris; F Kanakoudi-Tsakalidou; D Papakosta; V Tzimouli; A Taparkou; M Ventouri; I Tsanakas
Journal:  Hippokratia       Date:  2010-04       Impact factor: 0.471

4.  Intrapulmonary protein leakage in immunocompromised children and adults with pneumonia.

Authors:  F Ratjen; W Havers; J Braun
Journal:  Thorax       Date:  1999-05       Impact factor: 9.139

5.  Selective up-regulation of chemokine IL-8 expression in cystic fibrosis bronchial gland cells in vivo and in vitro.

Authors:  O Tabary; J M Zahm; J Hinnrasky; J P Couetil; P Cornillet; M Guenounou; D Gaillard; E Puchelle; J Jacquot
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

6.  Changes in gastric and lung microflora with acid suppression: acid suppression and bacterial growth.

Authors:  Rachel Rosen; Janine Amirault; Hongye Liu; Paul Mitchell; Lan Hu; Umakanth Khatwa; Andrew Onderdonk
Journal:  JAMA Pediatr       Date:  2014-10       Impact factor: 16.193

7.  Interstitial Lung Disease in Children Older Than 2 Years.

Authors:  Timothy J Vece; Leland L Fan
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2010-03       Impact factor: 1.349

8.  Suppression of autologous peripheral blood mononuclear cell proliferation by alveolar macrophages from young infants.

Authors:  H J Bunn; C R A Hewitt; J Grigg
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

9.  Regulation of gap junctional communication by a pro-inflammatory cytokine in cystic fibrosis transmembrane conductance regulator-expressing but not cystic fibrosis airway cells.

Authors:  M Chanson; P Y Berclaz; I Scerri; T Dudez; K Wernke-Dollries; L Pizurki; A Pavirani; M A Fiedler; S Suter
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

10.  Inducible NO synthase expression is low in airway epithelium from young children with cystic fibrosis.

Authors:  A Moeller; F Horak; C Lane; D Knight; A Kicic; S Brennan; P Franklin; J Terpolilli; J H Wildhaber; S M Stick
Journal:  Thorax       Date:  2006-03-03       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.